All stock lists
Matinas BioPharma Holdings, Inc. (New York Stock Exchange Arca:MTNB)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.68-0.02 (-1.21%)
Insider Score
––Not scored
MTNB Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
MTNB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 4.00 K | 74.00 K | -85.00 K | 114.00 K | 124.00 K | 85.00 K |
| Gross Profit | -4.00 K | -74.00 K | 85.00 K | -114.00 K | -124.00 K | -85.00 K |
| SG&A Expense | 1.55 M | 1.94 M | 1.60 M | 1.46 M | 1.71 M | 1.86 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 85.00 K |
| Operating Expenses | 1.55 M | 1.86 M | 1.69 M | 1.46 M | 1.71 M | 1.86 M |
| Operating Income | -1.55 M | -1.94 M | -1.60 M | -1.58 M | -1.84 M | -1.95 M |
| Pretax Income | -1.33 M | -1.92 M | -1.91 M | -2.15 M | -5.25 M | -1.66 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.33 M | -1.92 M | -1.91 M | -2.15 M | -5.25 M | -1.66 M |
| EPS (Basic) | -3.15 | -4.50 | -4.50 | -6.00 | -15.45 | -4.95 |
| EPS (Diluted) | -3.15 | -4.50 | -4.50 | -6.00 | -15.45 | -4.95 |
| Shares Outstanding | 427.08 K | 427.08 K | 364.94 K | 362.39 K | 339.13 K | 339.13 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.